India, May 29 -- Nikkhil K Masurkar, CEO of Mumbai-based Entod Pharmaceuticals, has been appointed Vice Chairperson of the R&D and Innovation Committee of the Indian Drug Manufacturers Association (IDMA) for the 2025-2026 term.
As India's largest pharmaceutical industry body, IDMA represents over 1,100 member companies, the majority of which are Micro, Small, and Medium Enterprises (MSMEs).
Masurkar's strong leadership qualities, dynamic entrepreneurial spirit and sharp business acumen together with impressive pharmaceutical & research skills have made Entod Pharmaceuticals into one of the fastest growing speciality pharmaceutical & healthcare companies in India and abroad.
The R&D and Innovation Committee of IDMA plays a vital role in...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.